Duchenne News Tags: Pfizer

August 5, 2024
Pfizer announces discontinuation of investigation into CIFFREO gene therapy for Duchenne.
May 7, 2024
Tuesday, May 7, 2024 – We at Jett Foundation are deeply saddened to learn about the devastating loss of a child participating in Pfizer’s Phase 2 DAYLIGHT clinical trial for...